| Last Action | to Health & Welfare (S) | 
|---|---|
| Title | AN ACT relating to abuse-deterrent opioid analgesic drug products. | 
| Bill Documents | Bill | 
| Impact Statements | Health Mandate | 
| Bill Request Number | 990 | 
| Sponsors | A. Wuchner, J. Jenkins, L. Belcher, K. Flood, R. Huff, K. King, M. King, M. Marzian, D. Mayfield, M. Rader, R. Smart, D. St. Onge, S. Westrom, J. York | 
| Summary of Original Version | Create a new section of KRS Chapter 217 to define terms, prohibit substitution or dispensing an equivalent drug product without documentation from a prescribing health care practitioner; create a new section of subtitle 17A of KRS Chapter 304 to define terms and limit cost sharing for generic abuse-deterrent opioid analgesic drug products; create a new section of KRS Chapter 205 to permit Medicaid compliance. | 
| Index Headings of Original Version | Health Benefit Mandate - Abuse-deterrent opioid analgesic drug product, substitution Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution Medicaid - Abuse-deterrent opioid analgesic drug product, substitution | 
| Proposed Amendments | House Committee Substitute 1 House Floor Amendment 1 | 
| Votes | Vote History | 
| 02/02/16 | 
 | 
|---|---|
| 02/04/16 | 
 | 
| 03/10/16 | 
 | 
| 03/11/16 | 
 | 
| 03/14/16 | 
 | 
| 03/15/16 | 
 | 
| 03/18/16 | 
 | 
| 03/21/16 | 
 | 
| 03/23/16 | 
 | 
| 03/24/16 | 
 | 
| Amendment | House Committee Substitute 1 | 
|---|---|
| Impact Statements | Health Mandate | 
| Summary | Amend to delete insurer. | 
| Index Headings | Health Benefit Mandate - Abuse-deterrent opioid analgesic drug product, substitution Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution Medicaid - Abuse-deterrent opioid analgesic drug product, substitution | 
| Amendment | House Floor Amendment 1 | 
|---|---|
| Sponsor | A. Wuchner | 
| Summary | Amend to encourage coverage of two and require coverage of one abuse-deterrent opioid analgesic drug products. | 
| Index Headings | Health Benefit Mandate - Abuse-deterrent opioid analgesic drug product, substitution Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution Medicaid - Abuse-deterrent opioid analgesic drug product, substitution | 
Last updated: 1/16/2019 3:08 PM (EST)